[go: up one dir, main page]

AU1746601A - Method of covalent coupling - Google Patents

Method of covalent coupling

Info

Publication number
AU1746601A
AU1746601A AU17466/01A AU1746601A AU1746601A AU 1746601 A AU1746601 A AU 1746601A AU 17466/01 A AU17466/01 A AU 17466/01A AU 1746601 A AU1746601 A AU 1746601A AU 1746601 A AU1746601 A AU 1746601A
Authority
AU
Australia
Prior art keywords
covalent coupling
covalent
coupling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17466/01A
Inventor
Ibrahim Gouda
Olle Larm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medicarb AB
Original Assignee
Medicarb AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicarb AB filed Critical Medicarb AB
Publication of AU1746601A publication Critical patent/AU1746601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/08—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Materials For Medical Uses (AREA)
AU17466/01A 1999-11-23 2000-11-09 Method of covalent coupling Abandoned AU1746601A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9904241 1999-11-23
SE9904241A SE515295C2 (en) 1999-11-23 1999-11-23 Process for the preparation of conjugates of a biologically active polysaccharide and a solid substrate, and such conjugates
PCT/SE2000/002198 WO2001037893A1 (en) 1999-11-23 2000-11-09 Method of covalent coupling

Publications (1)

Publication Number Publication Date
AU1746601A true AU1746601A (en) 2001-06-04

Family

ID=20417829

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17466/01A Abandoned AU1746601A (en) 1999-11-23 2000-11-09 Method of covalent coupling

Country Status (6)

Country Link
US (1) US6653457B1 (en)
EP (1) EP1231952A1 (en)
JP (1) JP2003514957A (en)
AU (1) AU1746601A (en)
SE (1) SE515295C2 (en)
WO (1) WO2001037893A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10152407A1 (en) * 2001-10-24 2003-05-08 Aesculap Ag & Co Kg Composition of at least two biocompatible chemically crosslinkable components
PT1835938E (en) 2004-12-27 2013-11-06 Baxter Int Polymer-von willebrand factor-conjugates
CA2630823C (en) 2005-12-13 2015-02-10 Exthera Ab Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
BRPI0708832A2 (en) 2006-03-31 2011-06-14 Baxter Int proteinacean construction
US7645860B2 (en) 2006-03-31 2010-01-12 Baxter Healthcare S.A. Factor VIII polymer conjugates
US8021677B2 (en) 2006-05-12 2011-09-20 Gore Enterprise Holdings, Inc. Immobilized biologically active entities having a high degree of biological activity
JP2010530288A (en) * 2007-06-18 2010-09-09 エクステラ・メディカル・エルエルシー Device and method for recovering blood condition
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
GB0816783D0 (en) * 2008-09-15 2008-10-22 Carmeda Ab Immobilised biological entities
US8591932B2 (en) * 2009-09-17 2013-11-26 W. L. Gore & Associates, Inc. Heparin entities and methods of use
JP5925693B2 (en) 2009-12-01 2016-05-25 エクステラ・メディカル・コーポレーション Method for removing cytokines from blood using surface-immobilized polysaccharides
GB201004101D0 (en) 2010-03-12 2010-04-28 Carmeda Ab Immobilised biological entities
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
KR101933237B1 (en) 2011-03-11 2018-12-27 더블유.엘. 고어 앤드 어소시에이트스, 인코포레이티드 Improvements to immobilised biological entities
EP2861273B1 (en) 2012-06-13 2017-08-23 ExThera Medical Corporation Use of heparin and carbohydrates to treat cancer
ES2701077T3 (en) * 2012-11-29 2019-02-20 St Pharm Co Ltd Bile acid oligomer conjugate for new vesicular transport and use thereof
EP2950832B1 (en) 2013-02-04 2018-08-01 W. L. Gore & Associates, Inc. Coating for substrate
US9272075B2 (en) 2013-02-04 2016-03-01 W.L. Gore & Associates, Inc. Coating for substrate
EP3620218A1 (en) 2013-06-24 2020-03-11 ExThera Medical Corporation Blood filtration system containing mannose coated substrate
AU2014346668C1 (en) 2013-11-08 2018-04-26 Exthera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
US11839698B2 (en) 2014-03-13 2023-12-12 W. L. Gore & Associates, Inc. Drug composition and coating
CN106255520B (en) 2014-04-24 2022-08-12 艾克塞拉医疗公司 Method for removing bacteria from blood using high flow rate
WO2016048901A1 (en) 2014-09-22 2016-03-31 Exthera Medical Corporation Wearable hemoperfusion device
WO2017151797A1 (en) 2016-03-02 2017-09-08 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
US20190275213A1 (en) 2018-03-09 2019-09-12 Carmeda Ab Immobilising biological entities
CN116173297A (en) 2018-03-09 2023-05-30 卡梅达股份公司 Improvements in methods for immobilizing biological matter
CN113164660A (en) 2018-10-03 2021-07-23 卡梅达股份公司 Immobilized biological entities
EP3969014A4 (en) 2019-05-16 2023-01-25 ExThera Medical Corporation Method for modulating endothelial glycocalyx structure
CN110041445A (en) * 2019-05-17 2019-07-23 河南科技大学 A method of by preparing neutral polysaccharide in Syringa pubescens

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8200751L (en) * 1982-02-09 1983-08-10 Olle Larm PROCEDURE FOR COVALENT COUPLING FOR MANUFACTURE OF CONJUGATE AND REQUIRED PRODUCTS
SE453394B (en) 1986-07-07 1988-02-01 Pharmacia Ab PROCEDURE FOR PREPARING SULPHATATED POLYSACcharides BY USING A REDUCING AGENT FOR THE SULPHATING REACTION
JPH0778080B2 (en) * 1987-04-10 1995-08-23 雪印乳業株式会社 Method for separating and purifying lactoferrin from milk
SE470006B (en) 1991-09-26 1993-10-25 Corline Systems Ab New conjugate, its preparation and use, and substrates prepared with the conjugate
ES2111753T3 (en) * 1992-06-01 1998-03-16 Biomembrane Inst SEQUENTIAL SEPARATION OF MONOSACCHARIDS FROM THE EXTREME REDUCER OF OLIGOSACCHARIDS AND THEIR USES.
US5679659A (en) * 1995-08-22 1997-10-21 Medtronic, Inc. Method for making heparinized biomaterials
US5945319A (en) * 1996-04-25 1999-08-31 Medtronic, Inc. Periodate oxidative method for attachment of biomolecules to medical device surfaces
US5728420A (en) * 1996-08-09 1998-03-17 Medtronic, Inc. Oxidative method for attachment of glycoproteins to surfaces of medical devices
NO984143L (en) * 1998-09-09 2000-03-10 Norsk Hydro As New process for producing surface modifying substances

Also Published As

Publication number Publication date
EP1231952A1 (en) 2002-08-21
US6653457B1 (en) 2003-11-25
WO2001037893A1 (en) 2001-05-31
SE9904241D0 (en) 1999-11-23
SE515295C2 (en) 2001-07-09
SE9904241L (en) 2001-05-24
JP2003514957A (en) 2003-04-22

Similar Documents

Publication Publication Date Title
AU1746601A (en) Method of covalent coupling
AU3867400A (en) Methods of using bioelastomers
AU3803600A (en) Method of securing communication
AU2557500A (en) Methods of making compounds
AU3215500A (en) Compounds and methods
AU7989400A (en) Compounds and methods
EP1117159A3 (en) Connector
AU1854901A (en) Novel method
AU7078100A (en) Methods of identifying anti-viral agents
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
AU4819899A (en) Coupling half and method of making same
AU1893901A (en) Connector
AU7987700A (en) Substrate coupling method
AU5116100A (en) Connector and method of use of the connector
AU4156200A (en) Method of receiving information
AU2964500A (en) Method of micro-fabrication
AU2728901A (en) Method of making hydrofluorocarbons
AUPQ388399A0 (en) A method of transformation
AU5310600A (en) Process for deacylation of lipodepsipeptides
AU7746900A (en) Method of preparing phosphorus
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AU4367900A (en) Carbohydrate-modifying enzymes
AU4585100A (en) Method
AU5552200A (en) Method
AU4702900A (en) Method of making ionomeric particulates

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase